Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease

Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease

Manuscript Number: 

15-0376R1

Author(s): 
Nick C. Fox, Ann Holstein, Nicholas Jackson, Nzeera Ketter, Ghislaine Le Prince Leterme, Enchi Liu, Florence Pasquier, Yahong Peng, J. Michael Ryan, Carl Sadowsky
Source URL: https://www.j-alz.com/manuscript-disclosures/15-0376r1